Evidence map›Paper›PMID 28179064›Full record

ArticleSchizophrenia research2017

GABA and schizophrenia: Where we stand and where we need to go.

Jill R Glausier, David A Lewis

Abstract read
In one paragraph

Article in Schizophrenia research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Modulators of GABANeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Expression of the schizophrenia associated geneFrontiers in neuroscience · 2023
    Article
  9. Article
  10. GABACurrent topics in behavioral neurosciences · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Psychiatric-disorder-related behavioral phenotypes and cortical hyperactivity in a mouse model of 3q29 deletion syndrome.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jill R GlausierDepartment of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh, Biomedical Science Tower W1654, 3811 O'Hara Street, Pittsburgh, PA 15213, United States. Electronic address: glausierjr@upmc.edu.
David A LewisDepartment of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh, Biomedical Science Tower W1654, 3811 O'Hara Street, Pittsburgh, PA 15213, United States. Electronic address: lewisda@upmc.edu.

Funding

Statistics and Data Management CoreP50MH103204 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SWEET, ROBERT A · 2014 to 2018
$10.8M
SCHIZOPHRENIA AND CORTICAL DOPAMINE/GABA INTERACTIONSR01MH043784 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEWIS, DAVID A · 1988 to 2023
$7.2M
GABA Neurons and Cortical Circuitry in SchizophreniaR37MH043784 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEWIS, DAVID A · 2001 to 2010
$6.8M
Excitatory signaling and oxidative phosphorylation alterations in schizophreniaK01MH107735 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GLAUSIER, JILL RENEE' · 2016 to 2019
$640k
NIMH NIH HHS K01 MH107735NIMH NIH HHS P50 MH103204NIMH NIH HHS R01 MH043784NIMH NIH HHS R37 MH043784
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBraingamma-Aminobutyric AcidHumansSchizophreniagamma-Aminobutyric Acid

Identifiers

PMID28179064
PMCPMC5365350

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.